First Time Loading...

Alnylam Pharmaceuticals Inc
NASDAQ:ALNY

Watchlist Manager
Alnylam Pharmaceuticals Inc Logo
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Watchlist
Price: 150.24 USD 0.56% Market Closed
Updated: May 21, 2024

P/E
Price to Earnings

-57.2
Current
-23.5
Median
26.1
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-57.2
=
Market Cap
19B
/
Net Income
-332m
All Countries
Close

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-35.4
2-Years Forward
P/E
-84
3-Years Forward
P/E
65

See Also

Discover More